scholarly journals Premenopausal Osteoporosis

2017 ◽  
Vol 46 (1) ◽  
pp. 117-133 ◽  
Author(s):  
Adi Cohen
Keyword(s):  
Premenopausal Osteoporosis

Too young to break? A rare case of premenopausal osteoporosis

2021 ◽  
Vol 14 (10) ◽  
pp. e245241
Author(s):  
Iqra Patoli ◽  
Mian Zeeshan Munir ◽  
Sameerah Rehmani
Keyword(s):  
Rare Case ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Lumbosacral Spine ◽  
Genetic Profile ◽  
Thoracic Vertebrae ◽  
Lipoprotein Receptor ◽  
Density Lipoprotein Receptor ◽  
Premenopausal Osteoporosis ◽  
Premenopausal Female

We present a case of a 29-year-old female with fragility fracture of the ninth thoracic vertebrae with a z-score of −3.3 of the lumbosacral spine. She was worked up for secondary causes of osteoporosis, all of which was unrevealing except for a low vitamin D level which was repleted. She had genetic profile done, which revealed low-density lipoprotein receptor-related 5 mutation which was thought to the cause of premature osteoporosis. This report highlights a rare case of osteoporosis in a premenopausal female and challenges associated with premenopausal osteoporosis.

scholarly journals Swimming as Treatment for Osteoporosis: A Systematic Review and Meta-analysis

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Yanlin Su ◽  
Zhe Chen ◽  
Wei Xie
Keyword(s):  
Meta Analysis ◽  
Relevant Literature ◽  
Premenopausal Women ◽  
Current Evidence ◽  
Spine Density ◽  
Mineral Density ◽  
Randomized Controlled ◽  
Premenopausal Osteoporosis

Osteoporosis is a chronic disease that seriously affects human health and quality of life. This study is aimed at determining whether swimming had an effect on the bone mineral density (BMD) of the spine and femoral neck in postmenopausal and premenopausal osteoporosis patients. We retrieved relevant literature and analyzed data from randomized controlled trials to assess the effect of swimming on BMD in postmenopausal and premenopausal women. Relevant studies, with no language restrictions, from inception to September 2019, were retrieved from the PubMed, Cochrane, EMBASE, and EBSCO databases independently by two investigators. The keywords used for the literature search were “osteoporosis” and “swimming.” The main results included BMD and T-score. We searched 256 relevant articles and finally screened five articles, including 263 participants. Lumbar spine density was mentioned in three articles. Although the heterogeneity of lumbar vertebral density is moderate, the analysis of swimmers to nonswimmers shows that the lumbar vertebral density in swimmers is improved [heterogeneity: chi2=5.16, df=2 (P=0.08); I2=61%]. We analyzed the following heterogeneous subgroups: subgroup 1 (3–6 hours) and subgroup 2 (<3 hours). The BMD in subgroup 1 was significantly higher than that in the placebo, while no effect on BMD was found in subgroup 2 [heterogeneity: chi2=0.15, df=3 (P=0.70); I2=0%]. According to the current evidence, swimming may improve the BMD of postmenopausal women participants, if the swimming time is between 3 and 6 hours, especially in long-term swimmers. However, the effectiveness of swimming does require further investigation.

Premenopausal Osteoporosis: How to Treat?

2012 ◽  
Vol 8 (2) ◽  
pp. 93-97 ◽  
Author(s):  
Melania Martínez-Morillo ◽  
Dolors Grados ◽  
Susana Holgado
Keyword(s):  
Premenopausal Osteoporosis

scholarly journals Premenopausal Osteoporosis & Perfluoroalkyl Substance Exposure; Is There a Link?

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A213-A213
Author(s):  
Bhavana Vemula ◽  
Omolola Bolaji Olajide
Keyword(s):  
Vitamin D ◽  
Lumbar Spine ◽  
Bone Density ◽  
Bone Mineralization ◽  
Consumer Products ◽  
Low Bone Density ◽  
Lower Lumbar Spine ◽  
Wide Range ◽  
Premenopausal Osteoporosis ◽  
History Of

Abstract Introduction: Perfluoroalkyl substances (PFAS) like Perflouroctanoate (PFOA) and Perflurooctane sulfonate (PFOS) are ubiquitous environmental contaminants that have been in industrial use for many years. Many known adverse effects include malignancies, reproductive and thyroid dysfunction. However, there is limited literature regarding PFAS causing low bone density. We report a case of a premenopausal woman with a history of exposure to PFAS who was recently diagnosed with osteoporosis. Clinical Case: A 36-year-old lady with a history of hypothyroidism, on levothyroxine, presented to the orthopedics clinic with complaints of sudden onset right foot pain with no trauma. She was found to have a fracture of her right second metatarsal bone. Notably, over a period of five years she had suffered multiple fractures including metatarsal, elbow and a wrist fracture, all with minimal or no trauma. She denied smoking, alcohol, chronic steroid or PPI use, history of malabsorption, celiac disease, kidney stones, malignancy or liver problems. Her menstrual cycles were regular; she was on oral contraceptives in the past for dysmenorrhea. She is on Vitamin D supplementation and consumes adequate dairy products daily. There is no family history of hip fracture or osteoporosis. Labs showed: Calcium 8.9mg/dl, Phosphorus 2.4mg/dl (2.5–4.5mg/dl), intact PTH was 92.7pg/ml (8-97pg/ml), 24-hour urine calcium was undetectable. Vitamin D was 56.6ng/ml (30-100ng/ml). CBC, TSH, FSH, liver & kidney functions were all normal. Anti-endomysial, anti-gliadin and anti-tissue trans glutaminase antibodies were all unremarkable. IgA level was 362mg/dl (8–352 mg/dl). DXA scan revealed the lowest Z-score (-3.1) in the lumbar spine. She reported a history of exposure to PFAS with a blood level of 22.3ng/ml for PFOA and 48.4ng/ml for PFOS in the year 2005. Plan is to initiate bisphosphonate therapy for the treatment of osteoporosis. Discussion: PFAS are known endocrine disruptive agents that have been used widely in making a wide range of consumer products including nonstick and stain-resistant coatings of cookware, food containers. Recent studies suggest that serum PFAS concentrations were associated with lower bone density. There was a higher incidence of lower lumbar spine bone density in patients exposed to PFOS. PFOA is believed to compete with calcitriol at the same binding site on Vitamin D receptor resulting in changes in the osteoblasts thereby decreasing bone mineralization. Conclusion: There needs to be increased awareness about the association of low bone density in patients exposed to PFAS. This is especially important in the evaluation of premenopausal osteoporosis. References: 1. Environ Health Perspect. 2016 Jan;124 (1):81–7, 2. J Clin Endocrinol Metab 2014; 99(6) 2173–2180, 3. Sci Rep 2020 Oct 8;1091):16789

Bisphosphonates for the Treatment of Premenopausal Osteoporosis: Perils, Pitfalls, and Pragmatism.

2010 ◽  
pp. P2-209-P2-209
Author(s):  
SK Dhaliwal ◽  
ES Nylen ◽  
KL Becker ◽  
MJ Thompson ◽  
SG Khosla
Keyword(s):  
Premenopausal Osteoporosis

scholarly journals Premenopausal osteoporosis

2013 ◽  
Vol 17 (2) ◽  
pp. 240 ◽  
Author(s):  
MarilynLee Cheng ◽  
Vishal Gupta
Keyword(s):  
Premenopausal Osteoporosis

Premenopausal Osteoporosis

Dietary Fiber ◽  
1990 ◽  
pp. 89-103
Author(s):  
Tom Lloyd ◽  
James R. Buchanan
Keyword(s):  
Premenopausal Osteoporosis
Sign in / Sign up

Export Citation Format

Share Document